With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.

Why FATF report on terror financing is relevant to the UPSC exam? What is the significance of topics such as carrying ...

By cultivating a connected and founder-first ecosystem, Michigan aims to prove that economic growth can be inclusive, ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

When used strategically, real-world data can shift care upstream, from hospitals to patients and communities, and from crisis response to prevention.

Even Big Pharma, often criticized for high prices, is now struggling to navigate this ecosystem. New drugs cost hundreds of millions, sometimes billions, to develop and get through FDA approval.

The 70-page report from the Make America Healthy Again Commission targets the pharmaceutical and food industries for growing rates of childhood chronic disease.

The pharmaceutical industry translated a wonky policy topic into a talking point repeated by a range of groups.

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...